This article has been retracted and replaced. Please see https://doi.org/10.1093/jamiaopen/ooae036 for details. The replacement article can be found at https://doi.org/10.1093/jamiaopen/ooae037.
Contributor Information
Kamil Can Kural, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States; School of Systems Biology, George Mason University, Manassas, VA 20110, United States.
Ilya Mazo, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States.
Mark Walderhaug, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States.
Luis Santana-Quintero, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States.
Konstantinos Karagiannis, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States.
Elaine E Thompson, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States.
Jeffrey A Kelman, Centers for Medicare & Medicaid Services, Washington, DC 20001, United States.
Ravi Goud, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD 20993, United States.